Global Polypeptide Drug Sales Market Report 2017

January 2017 | 121 pages | ID: G716E4CC1EAEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Polypeptide Drug

Revenue, means the sales value of Polypeptide Drug

This report studies sales (consumption) of Polypeptide Drug in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Novartis
• Merck Serono
• Ferring Pharmaceuticals
• Ipsen PHarma Biotech
• Lilly
• Asahi Kasei
• AstraZeneca
• SciClone Pharmaceuticals
• Takeda

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Polypeptide Drug in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Polypeptide Drug in each application, can be divided into

• Application 1
• Application 2

Contents

Global Polypeptide Drug Sales Market Report 2017

1 POLYPEPTIDE DRUG OVERVIEW

1.1 Product Overview and Scope of Polypeptide Drug
1.2 Classification of Polypeptide Drug
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Polypeptide Drug
  1.3.1 Application
  1.3.2 Application
1.4 Polypeptide Drug Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Polypeptide Drug (2012-2022)
  1.5.1 Global Polypeptide Drug Sales and Growth Rate (2012-2022)
  1.5.2 Global Polypeptide Drug Revenue and Growth Rate (2012-2022)

2 GLOBAL POLYPEPTIDE DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Polypeptide Drug Market Competition by Manufacturers
  2.1.1 Global Polypeptide Drug Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Polypeptide Drug Revenue and Share by Manufacturers (2012-2017)
2.2 Global Polypeptide Drug (Volume and Value) by Type
  2.2.1 Global Polypeptide Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Global Polypeptide Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Polypeptide Drug (Volume and Value) by Regions
  2.3.1 Global Polypeptide Drug Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Polypeptide Drug Revenue and Market Share by Regions (2012-2017)
2.4 Global Polypeptide Drug (Volume) by Application

3 UNITED STATES POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Polypeptide Drug Sales and Value (2012-2017)
  3.1.1 United States Polypeptide Drug Sales and Growth Rate (2012-2017)
  3.1.2 United States Polypeptide Drug Revenue and Growth Rate (2012-2017)
  3.1.3 United States Polypeptide Drug Sales Price Trend (2012-2017)
3.2 United States Polypeptide Drug Sales and Market Share by Manufacturers
3.3 United States Polypeptide Drug Sales and Market Share by Type
3.4 United States Polypeptide Drug Sales and Market Share by Application

4 CHINA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Polypeptide Drug Sales and Value (2012-2017)
  4.1.1 China Polypeptide Drug Sales and Growth Rate (2012-2017)
  4.1.2 China Polypeptide Drug Revenue and Growth Rate (2012-2017)
  4.1.3 China Polypeptide Drug Sales Price Trend (2012-2017)
4.2 China Polypeptide Drug Sales and Market Share by Manufacturers
4.3 China Polypeptide Drug Sales and Market Share by Type
4.4 China Polypeptide Drug Sales and Market Share by Application

5 EUROPE POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Polypeptide Drug Sales and Value (2012-2017)
  5.1.1 Europe Polypeptide Drug Sales and Growth Rate (2012-2017)
  5.1.2 Europe Polypeptide Drug Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Polypeptide Drug Sales Price Trend (2012-2017)
5.2 Europe Polypeptide Drug Sales and Market Share by Manufacturers
5.3 Europe Polypeptide Drug Sales and Market Share by Type
5.4 Europe Polypeptide Drug Sales and Market Share by Application

6 JAPAN POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Polypeptide Drug Sales and Value (2012-2017)
  6.1.1 Japan Polypeptide Drug Sales and Growth Rate (2012-2017)
  6.1.2 Japan Polypeptide Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Polypeptide Drug Sales Price Trend (2012-2017)
6.2 Japan Polypeptide Drug Sales and Market Share by Manufacturers
6.3 Japan Polypeptide Drug Sales and Market Share by Type
6.4 Japan Polypeptide Drug Sales and Market Share by Application

7 SOUTHEAST ASIA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Polypeptide Drug Sales and Value (2012-2017)
  7.1.1 Southeast Asia Polypeptide Drug Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Polypeptide Drug Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Polypeptide Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Polypeptide Drug Sales and Market Share by Manufacturers
7.3 Southeast Asia Polypeptide Drug Sales and Market Share by Type
7.4 Southeast Asia Polypeptide Drug Sales and Market Share by Application

8 INDIA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Polypeptide Drug Sales and Value (2012-2017)
  8.1.1 India Polypeptide Drug Sales and Growth Rate (2012-2017)
  8.1.2 India Polypeptide Drug Revenue and Growth Rate (2012-2017)
  8.1.3 India Polypeptide Drug Sales Price Trend (2012-2017)
8.2 India Polypeptide Drug Sales and Market Share by Manufacturers
8.3 India Polypeptide Drug Sales and Market Share by Type
8.4 India Polypeptide Drug Sales and Market Share by Application

9 GLOBAL POLYPEPTIDE DRUG MANUFACTURERS ANALYSIS

9.1 Novartis
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Polypeptide Drug Product Type, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Merck Serono
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Polypeptide Drug Product Type, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Ferring Pharmaceuticals
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Polypeptide Drug Product Type, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Ipsen PHarma Biotech
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Polypeptide Drug Product Type, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Lilly
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Polypeptide Drug Product Type, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Asahi Kasei
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Polypeptide Drug Product Type, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 AstraZeneca
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Polypeptide Drug Product Type, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 SciClone Pharmaceuticals
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Polypeptide Drug Product Type, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Takeda
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Polypeptide Drug Product Type, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview

10 POLYPEPTIDE DRUG MAUFACTURING COST ANALYSIS

10.1 Polypeptide Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Polypeptide Drug
10.3 Manufacturing Process Analysis of Polypeptide Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Polypeptide Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL POLYPEPTIDE DRUG MARKET FORECAST (2017-2022)

14.1 Global Polypeptide Drug Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Polypeptide Drug Price and Trend Forecast (2017-2022)
14.2 Global Polypeptide Drug Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Polypeptide Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Polypeptide Drug Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Polypeptide Drug Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Polypeptide Drug
Table Classification of Polypeptide Drug
Figure Global Sales Market Share of Polypeptide Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Polypeptide Drug
Figure Global Sales Market Share of Polypeptide Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure China Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Europe Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Japan Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure India Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Global Polypeptide Drug Sales and Growth Rate (2012-2022)
Figure Global Polypeptide Drug Revenue and Growth Rate (2012-2022)
Table Global Polypeptide Drug Sales of Key Manufacturers (2012-2017)
Table Global Polypeptide Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Polypeptide Drug Sales Share by Manufacturers
Figure 2016 Polypeptide Drug Sales Share by Manufacturers
Table Global Polypeptide Drug Revenue by Manufacturers (2012-2017)
Table Global Polypeptide Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Polypeptide Drug Revenue Share by Manufacturers
Table 2016 Global Polypeptide Drug Revenue Share by Manufacturers
Table Global Polypeptide Drug Sales and Market Share by Type (2012-2017)
Table Global Polypeptide Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Type (2012-2017)
Figure Global Polypeptide Drug Sales Growth Rate by Type (2012-2017)
Table Global Polypeptide Drug Revenue and Market Share by Type (2012-2017)
Table Global Polypeptide Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by Type (2012-2017)
Figure Global Polypeptide Drug Revenue Growth Rate by Type (2012-2017)
Table Global Polypeptide Drug Sales and Market Share by Regions (2012-2017)
Table Global Polypeptide Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Regions (2012-2017)
Figure Global Polypeptide Drug Sales Growth Rate by Regions (2012-2017)
Table Global Polypeptide Drug Revenue and Market Share by Regions (2012-2017)
Table Global Polypeptide Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by Regions (2012-2017)
Figure Global Polypeptide Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Polypeptide Drug Sales and Market Share by Application (2012-2017)
Table Global Polypeptide Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Application (2012-2017)
Figure Global Polypeptide Drug Sales Growth Rate by Application (2012-2017)
Figure United States Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure United States Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure United States Polypeptide Drug Sales Price Trend (2012-2017)
Table United States Polypeptide Drug Sales by Manufacturers (2012-2017)
Table United States Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table United States Polypeptide Drug Sales by Type (2012-2017)
Table United States Polypeptide Drug Market Share by Type (2012-2017)
Table United States Polypeptide Drug Sales by Application (2012-2017)
Table United States Polypeptide Drug Market Share by Application (2012-2017)
Figure China Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure China Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure China Polypeptide Drug Sales Price Trend (2012-2017)
Table China Polypeptide Drug Sales by Manufacturers (2012-2017)
Table China Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table China Polypeptide Drug Sales by Type (2012-2017)
Table China Polypeptide Drug Market Share by Type (2012-2017)
Table China Polypeptide Drug Sales by Application (2012-2017)
Table China Polypeptide Drug Market Share by Application (2012-2017)
Figure Europe Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Europe Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Europe Polypeptide Drug Sales Price Trend (2012-2017)
Table Europe Polypeptide Drug Sales by Manufacturers (2012-2017)
Table Europe Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table Europe Polypeptide Drug Sales by Type (2012-2017)
Table Europe Polypeptide Drug Market Share by Type (2012-2017)
Table Europe Polypeptide Drug Sales by Application (2012-2017)
Table Europe Polypeptide Drug Market Share by Application (2012-2017)
Figure Japan Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Japan Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Japan Polypeptide Drug Sales Price Trend (2012-2017)
Table Japan Polypeptide Drug Sales by Manufacturers (2012-2017)
Table Japan Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table Japan Polypeptide Drug Sales by Type (2012-2017)
Table Japan Polypeptide Drug Market Share by Type (2012-2017)
Table Japan Polypeptide Drug Sales by Application (2012-2017)
Table Japan Polypeptide Drug Market Share by Application (2012-2017)
Figure Southeast Asia Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Southeast Asia Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Polypeptide Drug Sales Price Trend (2012-2017)
Table Southeast Asia Polypeptide Drug Sales by Manufacturers (2012-2017)
Table Southeast Asia Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table Southeast Asia Polypeptide Drug Sales by Type (2012-2017)
Table Southeast Asia Polypeptide Drug Market Share by Type (2012-2017)
Table Southeast Asia Polypeptide Drug Sales by Application (2012-2017)
Table Southeast Asia Polypeptide Drug Market Share by Application (2012-2017)
Figure India Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure India Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure India Polypeptide Drug Sales Price Trend (2012-2017)
Table India Polypeptide Drug Sales by Manufacturers (2012-2017)
Table India Polypeptide Drug Market Share by Manufacturers (2012-2017)
Table India Polypeptide Drug Sales by Type (2012-2017)
Table India Polypeptide Drug Market Share by Type (2012-2017)
Table India Polypeptide Drug Sales by Application (2012-2017)
Table India Polypeptide Drug Market Share by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Polypeptide Drug Global Market Share (2012-2017)
Table Merck Serono Basic Information List
Table Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Serono Polypeptide Drug Global Market Share (2012-2017)
Table Ferring Pharmaceuticals Basic Information List
Table Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ferring Pharmaceuticals Polypeptide Drug Global Market Share (2012-2017)
Table Ipsen PHarma Biotech Basic Information List
Table Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ipsen PHarma Biotech Polypeptide Drug Global Market Share (2012-2017)
Table Lilly Basic Information List
Table Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lilly Polypeptide Drug Global Market Share (2012-2017)
Table Asahi Kasei Basic Information List
Table Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Asahi Kasei Polypeptide Drug Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Polypeptide Drug Global Market Share (2012-2017)
Table SciClone Pharmaceuticals Basic Information List
Table SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure SciClone Pharmaceuticals Polypeptide Drug Global Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Polypeptide Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure Global Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
Figure Global Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Table Global Polypeptide Drug Sales Forecast by Regions (2017-2022)
Table Global Polypeptide Drug Sales Forecast by Type (2017-2022)
Table Global Polypeptide Drug Sales Forecast by Application (2017-2022)